AccueilVeille ScientifiquePatient Access in 14 High-Income Countries to New Antibacterials Approved by the US Food and Drug Administration, European Medicines Agency, Japanese Pharmaceuticals and Medical Devices Agency, or Health Canada, 2010–2020

Clinical Infectious Diseases • 2021.07.12

Outterson K., Orubu E.S.F, Rex J., et al.